Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SYNAGEVA-BIOPHARMA-CORP-11900119/news/Synageva-Biopharma-European-Patent-Issued-For-Treatment-Of-LAL-Deficiency-19890464/?utm_source=whatsapp&utm_medium=social&utm_campaign=share